CR8823A - Metodos y composiciones para la cicatrizacion de heridas - Google Patents

Metodos y composiciones para la cicatrizacion de heridas

Info

Publication number
CR8823A
CR8823A CR8823A CR8823A CR8823A CR 8823 A CR8823 A CR 8823A CR 8823 A CR8823 A CR 8823A CR 8823 A CR8823 A CR 8823A CR 8823 A CR8823 A CR 8823A
Authority
CR
Costa Rica
Prior art keywords
methods
compositions
devices
cicatrization
wound
Prior art date
Application number
CR8823A
Other languages
English (en)
Inventor
Chandan K Sen
Original Assignee
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State Res Found filed Critical Univ Ohio State Res Found
Publication of CR8823A publication Critical patent/CR8823A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Metodos, dispositivos y composiciones para tratar lesiones en animales, que comprenden perxido de hidrogeno en concentraciones que son menores a las usada convencionalmente. Los metodos, dispositivos y composiones aceleran l acicatrizacion de heridas.
CR8823A 2004-06-18 2006-12-18 Metodos y composiciones para la cicatrizacion de heridas CR8823A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/871,158 US20050281890A1 (en) 2004-06-18 2004-06-18 Methods and compositions for wound healing

Publications (1)

Publication Number Publication Date
CR8823A true CR8823A (es) 2008-03-18

Family

ID=35480874

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8823A CR8823A (es) 2004-06-18 2006-12-18 Metodos y composiciones para la cicatrizacion de heridas

Country Status (16)

Country Link
US (1) US20050281890A1 (es)
EP (1) EP1765368A4 (es)
JP (1) JP2008503485A (es)
KR (1) KR20070042927A (es)
CN (1) CN101022816A (es)
AP (1) AP2007003872A0 (es)
AU (1) AU2005265115A1 (es)
BR (1) BRPI0510925A (es)
CA (1) CA2580381A1 (es)
CR (1) CR8823A (es)
EA (1) EA200700074A1 (es)
EC (1) ECSP077153A (es)
GB (1) GB2434983B (es)
IL (1) IL180128A0 (es)
WO (1) WO2006009853A1 (es)
ZA (1) ZA200610781B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103767886B (zh) 2005-11-09 2018-04-24 科洛斯科技公司 使牙齿增白的组合物及方法
JP5436205B2 (ja) * 2006-05-12 2014-03-05 スミス アンド ネフュー ピーエルシー 足場
CN101443272A (zh) * 2006-05-15 2009-05-27 弗吉尼亚联邦大学 用于受控和持续产生并输送过氧化物的方法和组合物
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
WO2008102247A2 (en) * 2007-02-23 2008-08-28 University Of The Witwatersrand, Johannesburg A polyamide rate-modulated monolithic drug delivery system
AU2008236622B2 (en) 2007-04-09 2013-01-10 Wake Forest University Health Sciences Oxygen-generating compositions for enhancing cell and tissue survival in vivo
EP2252333A4 (en) * 2008-02-13 2013-07-10 Oxygen Biotherapeutics Inc WOUND AND TISSUE THERAPY ON GAS BASIS
US8404752B2 (en) * 2008-07-18 2013-03-26 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
KR20180023070A (ko) 2008-11-07 2018-03-06 클록스 테크놀로지스 인크. 히알루론산, 글루코사민 또는 알란토인을 포함하는 산화성의 광활성화된 피부 회춘용 조성물
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
SG177635A1 (en) 2009-07-17 2012-03-29 Klox Technologies Inc Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
WO2011014247A1 (en) * 2009-07-28 2011-02-03 Oxygen Biotherapeutics, Inc. Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
US8778387B2 (en) * 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
SG182452A1 (en) 2010-01-22 2012-08-30 Hyprotek Inc Antimicrobial agent comprising peroxide, alcohol and chelating agent
WO2012044963A2 (en) 2010-10-01 2012-04-05 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus
US9192443B2 (en) 2012-02-06 2015-11-24 Hyprotek, Inc. Combined cap applicators
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
BR112015005593B1 (pt) 2012-09-14 2019-09-24 Valeant Pharmaceuticals International, Inc. Método para branqueamento de dentes
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
WO2015000058A1 (en) 2013-07-03 2015-01-08 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. 組織充填剤組成物および使用方法
EP3212826B1 (en) 2014-10-31 2020-10-14 Klox Technologies Inc. Photoactivatable fibers and fabric media
WO2016187093A1 (en) * 2015-05-15 2016-11-24 Garcia Carlos Diego Scent control compositions
CN106376423A (zh) * 2016-08-28 2017-02-08 铜仁市万山区山地葡萄科技有限公司 一种葡萄树伤流的救治方法
JP2023551063A (ja) * 2020-12-01 2023-12-06 カステラーナ,ロッサーナ 皮膚及び粘膜の外傷性病変を治癒するための製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163800A (en) * 1977-08-17 1979-08-07 The Procter & Gamble Company Topical composition and treatment of skin lesions therewith
GB9225581D0 (en) * 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
EP1244476B1 (en) * 1999-12-30 2006-05-31 Acrymed Methods and compositions for improved delivery devices
EP1353679A2 (en) * 2001-01-22 2003-10-22 Randolph M. Howes Compositions, methods and apparatuses for singlet oxygen delivery
EP1519750A2 (en) * 2002-03-28 2005-04-06 Exponential Biotherapies, Inc. Oxygenating agents for enhancing host responses to microbial infections
US6949240B2 (en) * 2002-05-23 2005-09-27 The Procter & Gamble Company Tooth whitening products
US20040001878A1 (en) * 2002-06-26 2004-01-01 Deroyal Industries, Inc. Infused wound care dressings
US8956160B2 (en) * 2002-07-02 2015-02-17 Ranir, Llc Device and method for delivering an oral care agent

Also Published As

Publication number Publication date
GB0700356D0 (en) 2007-02-14
GB2434983A (en) 2007-08-15
CA2580381A1 (en) 2006-01-26
US20050281890A1 (en) 2005-12-22
ZA200610781B (en) 2010-05-26
AU2005265115A1 (en) 2006-01-26
AP2007003872A0 (en) 2007-02-28
CN101022816A (zh) 2007-08-22
IL180128A0 (en) 2007-06-03
JP2008503485A (ja) 2008-02-07
EP1765368A1 (en) 2007-03-28
KR20070042927A (ko) 2007-04-24
GB2434983B (en) 2009-01-28
ECSP077153A (es) 2007-04-26
EA200700074A1 (ru) 2007-08-31
EP1765368A4 (en) 2010-06-02
HK1103642A1 (zh) 2007-12-28
WO2006009853A1 (en) 2006-01-26
BRPI0510925A (pt) 2007-11-13

Similar Documents

Publication Publication Date Title
ECSP077153A (es) Métodos y composiciones para la cicatrización de heridas
CR9869A (es) Compuestos activos en ppar
SG158153A1 (en) Compositions and methods for promoting wound healing and tissue regeneration
AR018674A1 (es) Aparato para tratar un volumen particular de tejido vegetal o animal que contiene por lo menos un agente.
AU2016204344A1 (en) Improved methods and compositions for wound healing
UY27729A1 (es) Inhibidores de quinasas.
MX346450B (es) Composiciones y métodos para el tratamiento de la enfermedad celíaca.
BRPI0618086A8 (pt) Método, aparelho, produto de programa de computador e dispositivo para programação de transmissão de dados para melhorar a eficiência do consumo de potência em uma rede sem fio
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
ATE407967T1 (de) Nukleierungsmittel
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
CU20070261A7 (es) Compuestos de motilida
PA8597501A1 (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
MX2010012593A (es) Metodos para el tratamiento de lesion asociada con exposicion a especie alcalina.
CY1112607T1 (el) Εντομοκτονοι συνδυασμοι που περιλαμβανουν αβαμεκτινη και κυφλουμετοφενη
WO2013070670A8 (en) Device for tendon and ligament treatment
BRPI0821116A2 (pt) Composto, composição farmacêutica que o contem, uso deste e método para tratar qualquer mamífero afetado por câncer
GT201000175A (es) Uso de derivados de ácido tetrámico para controlar nematodos
CR9419A (es) Composiciones herbicidas basadas en 3-feniluracilos y 3-sulfonilisoxazolinas
PA8618401A1 (es) Prevencion y tratamiento de enfermedades cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1.3,5(10)-trien-3,16alfa-diol
DE602004025050D1 (de) Spinosyne für die wundheilung
WO2008057204A3 (en) Solid composition for treating water

Legal Events

Date Code Title Description
FC Refusal